Silco Pharmaceuticals Limited
  • Home
  • About Us
  • Products
    • Product Catalogue
  • Facilities
  • Investor
    • Notice
    • Annual Report & Audited Accounts
    • New Annual Report & Audited Accounts
    • Half Yearly Reports
    • Quarterly Reports
      • First Quarter Accounts ended Sep. 30, 2025
    • Price Sensitive Information (PSI)
    • Code of Conduct
    • Dividend Compliance Report
    • Dividend Disbursement Policy
    • Unpaid/Unclaimed Dividend
    • Prospectus
    • TT clean rate
    • Utilization Report
  • Global Operations
  • Contact Us
Select Page

Shop

Showing 217–228 of 231 results

  • Thiamine Mononitrate (B1) ,  Riboflavin (B2 ) , Pyridoxine HCl (B6) , Nicotinamide , ZnSO4.H20

    Thiamine Mononitrate (B1) , Riboflavin (B2 ) , Pyridoxine HCl (B6) , Nicotinamide , ZnSO4.H20

  • Tiemonium Methylsulphate

    Tiemonium Methylsulphate

  • Tifsi Syrup

    Tifsi Syrup

  • Tifsi Tablet

    Tifsi Tablet

  • Vitamin A Propionate , Vitamin D , Vitamin E Acetate , Ascorbic Acid , Thiamine HCl (B1) , Riboflavin 5- Phosphate Sodium (B2), Pyridoxine HCl , Nicotinamide , Cod Liver Oil .

    Vitamin A Propionate , Vitamin D , Vitamin E Acetate , Ascorbic Acid , Thiamine HCl (B1) , Riboflavin 5- Phosphate Sodium (B2), Pyridoxine HCl , Nicotinamide , Cod Liver Oil .

  • Viton 100ml Syrup

    Viton 100ml Syrup

  • Viton 200ml Syrup

    Viton 200ml Syrup

  • Viton EC Tablet

    Viton EC Tablet

  • Viton-B Tablet

    Viton-B Tablet

  • Viton-M Tablet

    Viton-M Tablet

  • Viton-Z Syrup

    Viton-Z Syrup

  • Viton-Z Tablet

    Viton-Z Tablet

  • ←
  • 1
  • 2
  • 3
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • →

Registered & Head Office

Nurani-41, Ban-Kalapara, Subid Bazar, Sylhet-3100, Bangladesh.

Phone: +8802996638241

E-mail:  info@silcopharma.com

 

 

 

 

 

 

 

 

 

 

 

 

 

ABOUT US

  • Home
  • About Us
  • Products
    • Product Catalogue
  • Facilities
  • Investor
    • Notice
    • Annual Report & Audited Accounts
    • New Annual Report & Audited Accounts
    • Half Yearly Reports
    • Quarterly Reports
      • First Quarter Accounts ended Sep. 30, 2025
    • Price Sensitive Information (PSI)
    • Code of Conduct
    • Dividend Compliance Report
    • Dividend Disbursement Policy
    • Unpaid/Unclaimed Dividend
    • Prospectus
    • TT clean rate
    • Utilization Report
  • Global Operations
  • Contact Us

PRODUCTS

  • By Trade Name
  • By Generic Name
  • By Therapeutic Class

FACILITIES

  • Quality Policy
  • Manufacturing Facility
  • Quality Assurance
  • HVAC system
  • Cephalosporin Unit
  • Wastewater Treatment
  • Facebook
  • Twitter
  • Google
  • Youtube
  • RSS
© Silcopharma 2024 || Designed and Develop by Momi Technology LLC